Comparative Effectiveness of SBRT
摘要
Stereotactic body radiation therapy (SBRT) is increasingly becoming an effective alternative to other treatment modalities in the treatment of cancer. Evidence from a variety of different data sources including prospective and retrospective series, large database analyses, and cost-effectiveness studies demonstrates that SBRT is effective in the treatment of brain, prostate, lung, liver, pancreatic, and renal cancers, often in the setting of oligometastatic disease. As the use of SBRT increases and long-term follow-up of patients after SBRT treatment grows, there will continue to be advances in this emerging area of research.